Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

We observed positive associations between 25(OH)D and hs-CRP in vitamin D-sufficient children.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Randomised controlled trial.

Randomised controlled trial

Assigns participants or groups to comparison interventions by chance.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

We performed a longitudinal study using data collected in the VIDI study, a randomized controlled trial of daily 10 µg (400 IU) (referred as group 10) or 30 µg (1200 IU) (referred as group 30) vitamin D3 supplementation administered to healthy infants from age 2 weeks to 2 years.

Source: Methods.

We began the VIDI follow-up study (VIDI2) in 2019 when participants were turning 6 years of age.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Low-grade inflammation from prenatal period to age 6 to 8 years in a Vitamin D trial

Randomised controlled trial · Pediatric Research · 2024

Original publication title

Low-grade inflammation from prenatal period to age 6 to 8 years in a Vitamin D trial

Helena H. Hauta-alus; Jenni Rosendahl; Elisa M. Holmlund-Suila; Saara M. Valkama; Maria Enlund-Cerullo; Markku Nurhonen; Eero Kajantie; Outi Mäkitie; Sture Andersson

© The Author(s) 2024

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Our results indicate that in children, inflammation, assessed by hs-CRP, persists from birth until 6 to 8 years. We observed positive associations between 25(OH)D and hs-CRP in vitamin D-sufficient children.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Low-grade systemic inflammation measured as high sensitivity C-reactive protein (hs-CRP) has been associated with non-communicable disease risk. We assessed whether prenatal inflammation and early-childhood vitamin D are associated with inflammation until age 6 to 8.

Source: Background

Abstract: What methods does the paper describe?

We analyzed blood hs-CRP and 25-hydroxy vitamin D [25(OH)D] in pregnancy, at birth from umbilical cord blood (UCB), from offspring at ages 1, 2, and 6 to 8 years in the Vitamin D Intervention in Infants (VIDI) study. VIDI was a randomized-controlled trial of vitamin D supplementation of 10 μg/day or 30 μg/day from age 2 weeks until 2 years in 975 infants recruited in 2013 to 14, with follow-up at age 6 to 8 in 2019 to 21 (n = 283).

Source: Methods

Abstract: Impact

  • High sensitivity C-reactive protein (hs-CRP) concentrations tract from birth to age 8 years

  • Our novel finding suggests a long-lasting pro-inflammatory phenotype in the child

  • Higher vitamin D concentration: but not dose: is associated with higher childhood hs-CRP

  • Chronic disease risk related to inflammation may in part originate from the prenatal period or early childhood

  • Further studies are needed to investigate the effects of inflammation on long-term clinical health outcomes

Source: Impact

Abstract: Results

Pregnancy hs-CRP was associated with UCB hs-CRP (r = 0.18, p < 0.001) but not independently with childhood hs-CRP (Estimate [95% CI] 0.04 [<−0.00, 0.09]). Higher UCB hs-CRP was associated independently with higher hs-CRP until 6 to 8 years (0.20 [0.12, 0.29]). Infant vitamin D dose had no effect on longitudinal hs-CRP (6 to 8 years, 0.11 [−0.04, 0.25]). Childhood 25(OH)D were associated positively with hs-CRP until age 6 to 8 (0.01 [>0.00, 0.01]).

Source: Results

Abstract: Conclusion

Our results indicate that in children, inflammation, assessed by hs-CRP, persists from birth until 6 to 8 years. We observed positive associations between 25(OH)D and hs-CRP in vitamin D-sufficient children.

Source: Conclusion
Authors’ abstract

Background

Low-grade systemic inflammation measured as high sensitivity C-reactive protein (hs-CRP) has been associated with non-communicable disease risk. We assessed whether prenatal inflammation and early-childhood vitamin D are associated with inflammation until age 6 to 8.

Methods

We analyzed blood hs-CRP and 25-hydroxy vitamin D [25(OH)D] in pregnancy, at birth from umbilical cord blood (UCB), from offspring at ages 1, 2, and 6 to 8 years in the Vitamin D Intervention in Infants (VIDI) study. VIDI was a randomized-controlled trial of vitamin D supplementation of 10 μg/day or 30 μg/day from age 2 weeks until 2 years in 975 infants recruited in 2013 to 14, with follow-up at age 6 to 8 in 2019 to 21 (n = 283).

Results

Pregnancy hs-CRP was associated with UCB hs-CRP (r = 0.18, p < 0.001) but not independently with childhood hs-CRP (Estimate [95% CI] 0.04 [<−0.00, 0.09]). Higher UCB hs-CRP was associated independently with higher hs-CRP until 6 to 8 years (0.20 [0.12, 0.29]). Infant vitamin D dose had no effect on longitudinal hs-CRP (6 to 8 years, 0.11 [−0.04, 0.25]). Childhood 25(OH)D were associated positively with hs-CRP until age 6 to 8 (0.01 [>0.00, 0.01]).

Conclusion

Our results indicate that in children, inflammation, assessed by hs-CRP, persists from birth until 6 to 8 years. We observed positive associations between 25(OH)D and hs-CRP in vitamin D-sufficient children.

Impact

  • High sensitivity C-reactive protein (hs-CRP) concentrations tract from birth to age 8 years

  • Our novel finding suggests a long-lasting pro-inflammatory phenotype in the child

  • Higher vitamin D concentration: but not dose: is associated with higher childhood hs-CRP

  • Chronic disease risk related to inflammation may in part originate from the prenatal period or early childhood

  • Further studies are needed to investigate the effects of inflammation on long-term clinical health outcomes

Publication and source details

Original title: Low-grade inflammation from prenatal period to age 6 to 8 years in a Vitamin D trial

Helena H. Hauta-alus; Jenni Rosendahl; Elisa M. Holmlund-Suila; Saara M. Valkama; Maria Enlund-Cerullo; Markku Nurhonen; Eero Kajantie; Outi Mäkitie; Sture Andersson

Pediatric Research · 2024

© The Author(s) 2024https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T04:41:24.671788+00:00

DOI: 10.1038/s41390-024-03019-4 · PMC11126391